Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9321730 Method of making and administering quinoline derivatives as anti-cancer agents

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

April 26, 2016

Patent Application Number

11892188

Date Filed

August 21, 2007

Patent Citations Received

US Patent 12084430 Tricyclic urea compounds as JAK2 V617F inhibitors

0

US Patent 11780840 Tricyclic urea compounds as JAK2 V617F inhibitors

US Patent 11919908 Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors

0

US Patent 11958861 Spirocyclic lactams as JAK2 V617F inhibitors

0

US Patent 11661422 Tricyclic urea compounds as JAK2 V617F inhibitors

0

US Patent 11691971 Naphthyridinone compounds as JAK2 V617F inhibitors

0

US Patent 11753413 Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors

US Patent 11767323 Tricyclic pyridone compounds as JAK2 V617F inhibitors

Patent Primary Examiner

Samira Jean-Louis

Patent abstract

The present invention relates methods of preparing quinoline derivative compounds, and administering such compounds in the treatment of solid and non-solid tumors, notably on liver cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9321730 Method of making and administering quinoline derivatives as anti-cancer agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool